COGT Cogent Biosciences, Inc. Stock — fundamentals, financials & AI research · AlgoThesis

Stocks›Basic Materials›COGT

COGT

Name: AlgoThesis
Author: algothesis

Cogent Biosciences, Inc.

NasdaqResearch view

Basic Materials · Pharmaceutical Preparations · SEC EDGAR FY 2020-12-31

Price history

Interactive · live data via TradingView

🔒 Click to interact · scroll moves the page

Snapshot

SEC EDGAR · FY 2020-12-31

Revenue$7.9M

Net Income$-74.8M

Gross Profit—

Oper Income$-333.4M

EPS (dil)$-2.16

Rev/sh$0.05

FCF/sh$-1.56

Book/sh$1.37

Cash/sh$1.42

40+ fundamentals from SEC EDGAR (public domain) — deeper than a typical screener's ratio table.

Revenue & Earnings — fiscal year

$8.4M

2017

$9.7M

2018

$22.5M

2019

$7.9M

2020

Financials — annual

SEC EDGAR · last 4 FY

USD	FY2017	FY2018	FY2019	FY2020
Revenue	$8.4M	$9.7M	$22.5M	$7.9M
Gross Profit	—	—	—	—
Operating Income	$-26.2M	$-36.0M	$-32.2M	$-82.2M
Net Income	$-25.5M	$-34.5M	$-31.8M

Deep dive

Computed from the SEC EDGAR multi-year statements

Operating leverage — margins

GrossOperatingNet

COMMUNITY · $COGT0 theses

POST YOUR TAKE →

Related Stocks

Loading peers…

Ask AI about COGT Build basket with COGT Screener

Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.